Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Artículo Especial
Compounding pharmacies: necesidad de regulación
ante amenazas a la salud pública
Rev. O.F.I.L. 2015, 25;4:243-248 Fecha de recepción: 09/01/2015 - Fecha de aceptación: 16/03/2015
Lectora Dra. Ana Violeta Ovares de la Peña. Regente Farmacéutica en Preparaciones Magistrales Farmacéuticas PREMAFARMA
Correspondencia:
Angélica Garro Rodríguez
Regente Farmacéutica en Preparaciones Magistrales Farmacéuticas PREMAFARMA
San José (Costa Rica 10803)
Correo electrónico: angelicagarro@hotmail.com
243
Vol. 25 Nº 4 2015
Compounding pharmacies: need to control due Conclusions: The FDA must go further
and address the existing problems
to threats to public health caused by the regulatory gap of "com-
pounding pharmacies"; applying all
SUMMARY Besides, a comparative-deductive the necessary enforcement actions to
Aims: The present study aspired to analysis was applied regarding the re- establish mandatory regulations to
expose the current situation regar- gulation of this activity in Costa Rica; protect public health. The FDA must
ding the need of regulation of com- from which conclusions were provi- assume a more preventive role, rather
pounding pharmacies due to the ded in order to contribute to the ar- than its supervision and regulation is
human losses that non-aseptic prac- gument of this topic of particular limited as a response to events that
tices have occasioned, specifically in interest. have serious implications for public
hospital pharmacies in the United Results: Compounding pharmacies health. According to present laws in
States of America. have issued more than 50 drug re- the United States, compounded pre-
Method: In this descriptive analysis, calls in the past two years and in a parations are made for a particular pa-
it was necessary to study the follo- sampling of half the cases it was tient as indicated by the prescribing
wing main articles –“Safety, sanitary found that 20% involved the most physician, as well as in Costa Rica. Ho-
problems prompt many drug recalls” serious recall classification “dange- wever, certain compounding pharma-
published in USA Today; “Texas com- rous or defective product”. In addi- cies prepared batches for sale to the
pounding pharmacy recalls drugs tion, since 2012, the FDA has public or health care centers, disres-
after 15 infections” available in CBS conducted 148 inspections and eva- pecting current regulations. In Costa
News and “Texas compounding luators have reported unacceptable Rica, there is scarce regulation of this
pharmacy recalls all sterile product” security conditions in 9 out of 10 fa- activity, so it’s imperative that the Mi-
announced in Medscape Medical cilities. Finally, in the last year, the nistry of Health take actions to ensure
News– and contrasted with current FDA has issued 28 warning letters the safety of compounded prepara-
legislation in The United States Fede- more than in the last five years com- tions, especially sterile- and protect
ral Food, Drug, and Cosmetic Act. bined. public health.
Key Words: Compounding pharmacies, compounded preparations, public health, sterile drugs, aseptic.
5. Brooks M. Texas compounding pharmacy recalls all 8. Compounding Quality Act. Food and Drug Adminis-
sterile product. Medscape Medical News. 23 de di- tration. Disponible en: http://www.fda.gov/drugs/Gui-
ciembre, 2013. Disponible en: http://www.meds- danceComplianceRegulatoryInformation/PharmacyCo
cape.com/ viewarticle/818265. Consultado el 30 de mpounding/. Consultado el 5 de noviembre, 2014.
octubre, 2014. 9. Compounding and the FDA: Questions and Answers.
6. Nuestra América News. Anuncian retiro del mercado de Food and Drug Administration. Disponible en: http://
productos de farmacia de Texas por riesgo de infección. www.fda.gov/Drugs/GuidanceComplianceRegulator-
13 de agosto 2013. Disponible en: http://www.nuestra- yInformation/PharmacyCompounding/ucm339764.ht
mericanews.com/consumidor-y-salud/anuncian-retiro- m Consultado el 5 de noviembre, 2014.
del-mercado-de-productos-de-farmacia-de-texas-por-ries 10. FDA Implementation of the Compounding Quality Act.
go-de-infeccion . Consultado el 29 de octubre, 2014. Food and Drug Administration Disponible en: http://
7. Eisler P, Schnaars C. Safety, sanitary problems prompt www.fda.gov/Drugs/GuidanceComplianceRegulator-
many drug recalls. USA Today. 10 de octubre, 2014. yInformation/PharmacyCompounding/ucm375804.ht
Disponible en: http://www.usatoday.com/story/news/ m. Consultado el 5 de noviembre, 2014.
nation/2014/10/07/compounding-pharmacy-recalls- 11. Entrevista: Dra Ana Violeta Ovares de la Peña. Regente
inspections-contamination/16472741/. Consultado el Farmacéutica en Preparaciones Magistrales Farmacéu-
6 de noviembre, 2014. ticas PREMAFARMA. 4 de diciembre, 2014.
248